We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ex-Pfizer Business Development Director Joins Australian Drug Developer Agenix

News   Jun 05, 2012

 
Ex-Pfizer Business Development Director Joins Australian Drug Developer Agenix
 
 
 

RELATED ARTICLES

First-degree Relatives of Blood Cancer Patients at Greater Risk

News

Those with a parent, sibling or child affected by blood cancer are more likely to be diagnosed with the disease, according to a new study.

READ MORE

New Method to Synthesize and Screen Macrocyclic Compounds

News

Scientists at EPFL have found a way to generate libraries of more than 9,000 of macrocyclic molecules below 1 KDa, all with high structural diversity.

READ MORE

Ahead of Million-person Sequencing Program, NIH Funds Genetic Counseling Resource

News

The All of Us Research Program, part of the National Institutes of Health, has awarded $4.6 million in initial funding to Color, a health technology company in Burlingame, California, to establish the program’s nationwide genetic counseling resource.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE